Adult Autoimmune Myopathies (MAIA)
NCT04792931 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-02-05
Summary
This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.
Conditions
- Idiopathic Inflammatory Myopathies
Interventions
- OTHER
-
description of adult autoimmune myopathies
description of adult autoimmune myopathies
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-20
- Primary Completion
- 2030-05-20
- Completion
- 2030-05-20
Countries
- France
Study Locations
More Related Trials
-
Sporadic Inclusion Body Myositis Natural History Study
NCT05046821 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
Study of STIM1 Membrane Expression
NCT04978948 ·Status: RECRUITING
-
Disease-Modifying Treatments for Myasthenia Gravis
NCT03490539 ·Status: COMPLETED
-
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
NCT05408702 ·Status: COMPLETED
-
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
NCT07103746 ·Status: RECRUITING ·Phase: PHASE2
-
Molecular Profile of the Evolution of Inclusion Body Myositis
NCT03299335 ·Status: COMPLETED ·Phase: NA
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis
NCT03092154 ·Status: TERMINATED ·Phase: NA
-
Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
NCT04062019 ·Status: UNKNOWN ·Phase: PHASE2
-
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
NCT04535843 ·Status: RECRUITING
-
Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
NCT05868837 ·Status: RECRUITING ·Phase: PHASE3
-
The Evaluation of Belimumab in Myasthenia Gravis (MG)
NCT01480596 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
NCT05136976 ·Status: RECRUITING ·Phase: PHASE3
-
Renal Manifestations During Idiopathic Inflammatory Myopathies
NCT06904937 ·Status: RECRUITING
-
Cognitive Functioning in People With Myasthenia Graivs: Impact on Daily Life Activities, Work, Disability and Quality of Life
NCT06718855 ·Status: COMPLETED
-
MYOPROSP - a Prospective Cohort Study in Myositis
NCT02468895 ·Status: ACTIVE_NOT_RECRUITING
-
Belimumab in Idiopathic Inflammatory Myositis
NCT02347891 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Biotherapy Treatment on Features of Microcrystalline Polyarthritis
NCT04005625 ·Status: COMPLETED
-
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
NCT05379634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT06952413 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
NCT05332587 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarkers for Fatigue in Patients with Myasthenia Gravis
NCT06860347 ·Status: COMPLETED
-
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT03751644 ·Status: COMPLETED ·Phase: NA
-
Myasthenia Gravis and Psyche
NCT03205306 ·Status: COMPLETED